通过头和部状细胞癌瘤的癌症干细胞抑制CD80介导的T细胞
Mian Xiao1,2,3,4,5, Lin Qiu5, Qian Gao5
1Central Laboratory, Peking University School and Hospital of Stomatology, Beijing 100081, China.
Cells
|February 12, 2026
概括
向CD80在头部和部平状细胞癌 (HNSCC) 中可以改善对新辅助化疗免疫疗法的反应. 这种方法通过减少类似癌症干细胞的细胞和促进T细胞活性来增强抗瘤免疫力.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症干细胞生物学
背景情况:
- 新辅助化疗免疫疗法对头部和部状细胞癌 (HNSCC) 的治疗有前途.
- 改善患者对这种治疗的反应率是一个至关重要的未满足需求.
- 了解耐药机制是提高治疗疗效的关键.
研究的目的:
- 调查HNSCC中新辅助化疗免疫治疗反应不良的机制.
- 确定改善治疗结果的策略.
- 探索CD80在HNSCC化学免疫疗法耐药性中的作用.
主要方法:
- 癌症干细胞样细胞 (CSC) 种群的识别和表征.
- 与治疗反应相关的CD80表达的分析.
- 功能性测试评估CD80调制对瘤细胞行为的影响.
- 评估CD80抑制对免疫反应和T细胞细胞毒性的影响.
- 临床前的HNSCC模型来评估CD80阻断的治疗疗效.
主要成果:
- 一个CD80高的CSC群体在患者中得到了丰富,这些患者对化疗免疫治疗有部分反应.
- CD80表达与茎状性标志物相关 (ALDH高CD44+,BMI1+).
- CD80 knockdown 减少了瘤细胞干细胞,迁移和入侵;过度表达增强了这些.
- 抑制CD80促进了Th1免疫反应,IL-2的产生和T细胞细胞毒性.
- 在临床前模型中,CD80阻断降低了瘤负担,并增加了CD8+ T细胞透.
结论:
- CD80在HNSCC中起着双重作用,促进瘤干和恶性表型,同时抑制抗瘤免疫力.
- 向CD80可以克服对新辅助化学免疫疗法的耐药性.
- CD80阻塞是提高HNSCC治疗疗效的有希望的策略.
相关概念视频
Arteries of the Head and Neck
3.5K
The human body's intricate network of arteries ensures that every organ system receives the necessary oxygen and nutrients for optimal function. The arterial network in the head and neck region is particularly complex, providing vital blood flow to the brain, eyes, and other critical structures. Prominent arteries in this region include the internal carotid arteries and the vertebral arteries.
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
3.5K
Veins of Head and Neck
5.8K
The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
5.8K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
4.5K
A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
4.5K
Adult Stem Cells
33.9K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.9K
Embryonic Stem Cells
32.6K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.6K
Embryonic Stem Cells
5.2K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.2K


